Patent Assignment
Reel/Frame 060882/0010
Change of Name
Recorded: 2022-06-03
Pages: 39
Assignor
UNIVERSITÉ DE NANTES
Executed: 2021-10-01
Assignee
NANTES UNIVERSITÉ
1, QUAI DE TOURVILLE, BP 13522, NANTES CEDEX 1, F-44035, FRANCE
Covered Properties
(3)
Targeting O-Acetylated GD2 Ganglioside as a New Therapeutic and Diagnostic Strategy for Cancer Stem Cells Cancer
Antibody Against GD2-O-Acetylated Ganglioside with Pro-Apoptotic Activity
Targeting O-Acetylated GD2 Ganglioside as a New Therapeutic and Diagnostic Strategy for Cancer Stem Cells Cancer
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 8, 2015
From: BIRKLE, STEPHANE; COCHONNEAU, DENIS; DORVILLIUS, MYLENE; LE DOUSSAL, JEAN-MARC
To: OGD2 PHARMA; UNIVERSITE DE NANTES
Reel/Frame 037238/0065 →
Assignment of Assignor's Interest
Sep 8, 2016
From: LE DOUSSAL, JEAN-MARC; TERME, MICKAEL; DORVILLIUS, MYLENE
To: OGD2 PHARMA; UNIVERSITE DE NANTES
Reel/Frame 039671/0252 →
Assignment of Assignor's Interest
Oct 15, 2018
From: BIRKLE, STEPHANE; COCHONNEAU, DENIS; DORVILLIUS, MYIENE; LE DOUSSAL, JEAN-MARC
To: OGD2 PHARMA; UNIVERSITE DE NANTES
Reel/Frame 047159/0812 →
Corrective Assignment to Correct the Tyographical Error in Third and Fifth Inventors Name. Previously Recorded at Reel: 047159 Frame: 0812. Assignor(S) Hereby Confirms the Assignment.
Nov 8, 2018
From: BIRKLE, STEPHANE; COCHONNEAU, DENIS; DORVILLIUS, MYLENE; LE DOUSSAL, JEAN-MARC
To: OGD2 PHARMA; UNIVERSITE DE NANTES
Reel/Frame 048099/0832 →